Analytical interference of 4-hydroxy-3-methoxymethamphetamine with the measurement of plasma free normetanephrine by ultra-high pressure liquid chromatography-tandem mass spectrometry

Clinical Biochemistry

Volumn 47, Issue 12, 2014, Pages 1121-1123

  Dunand, Marielle ^a   Donzelli, Massimiliano ^b   Rickli, Anna ^b   Hysek, Cédric M ^b   Liechti, Matthias E ^b   Grouzmann, Eric ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^b UNIVERSITY OF BASEL   (Switzerland)

Author keywords

4 Hydroxy 3 methoxymethamphetamine; Normetanephrine; Ultra high pressure liquid chromatography tandem mass spectrometry

Indexed keywords

3 METHOXYMETHAMPHETAMINE; 3,4 METHYLENEDIOXYMETHAMPHETAMINE; 4 HYDROXY 3 METHOXYMETHAMPHETAMINE; NORMETADRENALIN; UNCLASSIFIED DRUG; 4-HYDROXY-3-METHOXYMETHAMPHETAMINE; METHAMPHETAMINE;

ADRENERGIC SYSTEM; ARTICLE; BLOOD SAMPLING; DRUG DETERMINATION; HUMAN; LABORATORY DIAGNOSIS; NORMAL HUMAN; PHARMACOPHORE; PRIORITY JOURNAL; TANDEM MASS SPECTROMETRY; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY; ANALOGS AND DERIVATIVES; BLOOD; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; PROCEDURES;

CHROMATOGRAPHY, HIGH PRESSURE LIQUID; HEALTHY VOLUNTEERS; HUMANS; METHAMPHETAMINE; NORMETANEPHRINE; TANDEM MASS SPECTROMETRY;

EID: 84905723394     PISSN: 00099120     EISSN: 18732933     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2014.04.003     Document Type: Article

References (10)

1. Manger W.M., Gifford R.W. In clinical and experimental pheochromocytoma 1996, Blackwell Science, Cambridge. 2nd ed.
2. Pacak K., Eisenhofer G., Ahlman H., Borstein S.R., Gimenez-Roqueplo A.P., Grossman A.B., et al. International Symposium on Pheochromocytoma. Pheochromocytoma: recommendations for clinical practice from the First International Symposium October 2005. Nat Clin Pract Endocrinol Metabol 2007, 3:92-102.
3. de Jong W.H., Graham K.S., van der Molen J.C., Links T.P., Morris M.R., Ross H.A., de Vries E.G., Kema I.P. Plasma free metanephrine measurement using automated online solid-phase extraction HPLC tandem mass spectrometry. Clin Chem 2007, 53:1684-1693.
4. Lagerstedt S.A., O'Kane D.J., Singh R.J. Measurement of plasma free metanephrine and normetanephrine by liquid chromatography-tandem mass spectrometry for diagnosis of pheochromocytoma. Clin Chem 2004, 50:603-611.
5. Marney L.C., Laha T.J., Baird G.S., Rainey P.M., Hoofnagle A.N. Isopropanol protein precipitation for the analysis of plasma free metanephrines by liquid chromatography-tandem mass spectrometry. Clin Chem 2008, 54:1729-1732.
6. Peaston R.T., Graham K.S., Chambers E., van der Molen J.C., Ball S. Performance of plasma free metanephrines measured by liquid chromatography-tandem mass spectrometry in the diagnosis of pheochromocytoma. Clin Chim Acta 2010, 411:546-552.
7. Grouzmann E., Matter M., Bilz S., Herren A., Triponez F., Henzen C., et al. Monoamine oxidase A down-regulation contributes to high metanephrine concentration in pheochromocytoma. J Clin Endocrinol Metab 2012, 97:2773-2781.
8. Twentyman J.M., Cradic K.W., Singh R.J., Grebe S.K. Ionic cross talk can lead to overestimation of 3-methoxytyramine during quantification of metanephrines by mass spectrometry. Clin Chem 2012, 58:1156-1158.
9. Hysek C.M., Simmler L.D., Schillinger N., Meyer N., Schmid Y., Donzelli M., et al. Pharmacokinetic and pharmacodynamic effects of methylphenidate and MDMA administered alone or in combination. Int J Neuropsychopharmacol 2014, 17:371-381.
10. Kolbrich E.A., Goodwin R.S., Gorelick D.A., Hayes R.J., Stein E.A., Huestis M.A. Plasma pharmacokinetics of 3,4-methylenedioxymethamphetamine after controlled oral administration to young adults. Ther Drug Monit 2008, 30:320-332.